391 related articles for article (PubMed ID: 28292235)
1. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
2. Contrast agents for MRI.
Shokrollahi H
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T
Shen Z; Chen T; Ma X; Ren W; Zhou Z; Zhu G; Zhang A; Liu Y; Song J; Li Z; Ruan H; Fan W; Lin L; Munasinghe J; Chen X; Wu A
ACS Nano; 2017 Nov; 11(11):10992-11004. PubMed ID: 29039917
[TBL] [Abstract][Full Text] [Related]
4. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
5. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
6. Disruptive chemical doping in a ferritin-based iron oxide nanoparticle to decrease r2 and enhance detection with T1-weighted MRI.
Clavijo Jordan MV; Beeman SC; Baldelomar EJ; Bennett KM
Contrast Media Mol Imaging; 2014; 9(5):323-32. PubMed ID: 24764110
[TBL] [Abstract][Full Text] [Related]
7. Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.
Wei H; Bruns OT; Kaul MG; Hansen EC; Barch M; Wiśniowska A; Chen O; Chen Y; Li N; Okada S; Cordero JM; Heine M; Farrar CT; Montana DM; Adam G; Ittrich H; Jasanoff A; Nielsen P; Bawendi MG
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2325-2330. PubMed ID: 28193901
[TBL] [Abstract][Full Text] [Related]
8. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging.
Bae KH; Kim YB; Lee Y; Hwang J; Park H; Park TG
Bioconjug Chem; 2010 Mar; 21(3):505-12. PubMed ID: 20166678
[TBL] [Abstract][Full Text] [Related]
9. Paramagnetic inorganic nanoparticles as T1 MRI contrast agents.
Lee SH; Kim BH; Na HB; Hyeon T
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):196-209. PubMed ID: 24123961
[TBL] [Abstract][Full Text] [Related]
10. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
11. Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
Huang G; Li H; Chen J; Zhao Z; Yang L; Chi X; Chen Z; Wang X; Gao J
Nanoscale; 2014 Sep; 6(17):10404-12. PubMed ID: 25079966
[TBL] [Abstract][Full Text] [Related]
12. Paramagnetic nanoparticle T1 and T2 MRI contrast agents.
Xu W; Kattel K; Park JY; Chang Y; Kim TJ; Lee GH
Phys Chem Chem Phys; 2012 Oct; 14(37):12687-700. PubMed ID: 22885983
[TBL] [Abstract][Full Text] [Related]
13. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K
Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995
[TBL] [Abstract][Full Text] [Related]
14. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
16. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging.
Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML
Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363
[TBL] [Abstract][Full Text] [Related]
17. Peptide-Decorated Ultrasmall Superparamagnetic Nanoparticles as Active Targeting MRI Contrast Agents for Ovarian Tumors.
Yin J; Yao D; Yin G; Huang Z; Pu X
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41038-41050. PubMed ID: 31618000
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
19. Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging.
Kim MH; Son HY; Kim GY; Park K; Huh YM; Haam S
Biomaterials; 2016 Sep; 101():121-30. PubMed ID: 27281684
[TBL] [Abstract][Full Text] [Related]
20. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
Ahmed N; Ahmad NM; Fessi H; Elaissari A
Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]